UK biotech Gyroscope Therapeutics is to merge with Orbit Biomedical of the US to create a specialist in gene therapies for eye diseases. The combined company – which will operate under the Gyroscope ...

French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...

Abstract: In recent decades, significant advancements have been made in microscale electromechanical systems (MEMS) for sensing and actuation. Standard semiconductor manufacturing techniques have ...

Abstract: Traditional control methods for MEMS gyroscopes are unable to fully cope with short-term fluctuations and long-term drift caused by environmental factors. Adaptive control (AC) strategies as ...